BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 35830202)

  • 1. Key challenges for in vitro testing of tobacco products for regulatory applications: Recommendations for dosimetry.
    Miller-Holt J; Behrsing H; Crooks I; Curren R; Demir K; Gafner J; Gillman G; Hollings M; Leverette R; Oldham M; Simms L; Stankowski LF; Thorne D; Wieczorek R; Moore MM
    Drug Test Anal; 2023 Oct; 15(10):1175-1188. PubMed ID: 35830202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Key Challenges and Recommendations for
    Moore MM; Abraham I; Ballantyne M; Behrsing H; Cao X; Clements J; Gaca M; Gillman G; Hashizume T; Heflich RH; Hurtado S; Jordan KG; Leverette R; McHugh D; Miller-Holt J; Phillips G; Recio L; Roy S; Scian M; Simms L; Smart DJ; Stankowski LF; Tarran R; Thorne D; Weber E; Wieczorek R; Yoshino K; Curren R
    Altern Lab Anim; 2023 Jan; 51(1):55-79. PubMed ID: 36821083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Key Challenges for
    Crooks I; Clements J; Curren R; Guo X; Hollings M; Lloyd M; Smart D; Thorne D; Weber E; Moore M
    Altern Lab Anim; 2024 Jan; 52(1):42-59. PubMed ID: 38055860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro exposure systems and dosimetry assessment tools for inhaled tobacco products: Workshop proceedings, conclusions and paths forward for in vitro model use.
    Behrsing H; Hill E; Raabe H; Tice R; Fitzpatrick S; Devlin R; Pinkerton K; Oberdörster G; Wright C; Wieczorek R; Aufderheide M; Steiner S; Krebs T; Asgharian B; Corley R; Oldham M; Adamson J; Li X; Rahman I; Grego S; Chu PH; McCullough S; Curren R
    Altern Lab Anim; 2017 Jul; 45(3):117-158. PubMed ID: 28816053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterisation of the borgwaldt LM4E system for in vitro exposures to undiluted aerosols from next generation tobacco and nicotine products (NGPs).
    Adamson J; Jaunky T; Thorne D; Gaça MD
    Food Chem Toxicol; 2018 Mar; 113():337-344. PubMed ID: 29421647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Applying new approach methodologies to assess next-generation tobacco and nicotine products.
    Thorne D; McHugh D; Simms L; Lee KM; Fujimoto H; Moses S; Gaca M
    Front Toxicol; 2024; 6():1376118. PubMed ID: 38938663
    [No Abstract]   [Full Text] [Related]  

  • 7. Accurate measurement of main aerosol constituents from heated tobacco products (HTPs): Implications for a fundamentally different aerosol.
    Gasparyan H; Mariner D; Wright C; Nicol J; Murphy J; Liu C; Proctor C
    Regul Toxicol Pharmacol; 2018 Nov; 99():131-141. PubMed ID: 30244041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterisation of a smoke/ aerosol exposure in vitro system (SAEIVS) for delivery of complex mixtures directly to cells at the air-liquid interface.
    Wieczorek R; Trelles Sticken E; Pour SJ; Chapman F; Röwer K; Otte S; Stevenson M; Simms L
    J Appl Toxicol; 2023 Jul; 43(7):1050-1063. PubMed ID: 36734622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer potencies and margin of exposure used for comparative risk assessment of heated tobacco products and electronic cigarettes aerosols with cigarette smoke.
    Rodrigo G; Jaccard G; Tafin Djoko D; Korneliou A; Esposito M; Belushkin M
    Arch Toxicol; 2021 Jan; 95(1):283-298. PubMed ID: 33025067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of machine-based puffing parameters on aerosol and smoke emissions from next generation nicotine inhalation products.
    McAdam K; Davis P; Ashmore L; Eaton D; Jakaj B; Eldridge A; Liu C
    Regul Toxicol Pharmacol; 2019 Feb; 101():156-165. PubMed ID: 30445136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparable Impairment of Vascular Endothelial Function by a Wide Range of Electronic Nicotine Delivery Devices.
    Rao P; Han DD; Tan K; Mohammadi L; Derakhshandeh R; Navabzadeh M; Goyal N; Springer ML
    Nicotine Tob Res; 2022 Jun; 24(7):1055-1062. PubMed ID: 35100430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Workplace smoke-free policies that allow heated tobacco products and electronic cigarettes use are associated with use of both these products and conventional tobacco smoking: the 2018 JASTIS study.
    Siripongvutikorn Y; Tabuchi T; Okawa S
    Tob Control; 2021 Mar; 30(2):147-154. PubMed ID: 32188769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An inter-laboratory in vitro assessment of cigarettes and next generation nicotine delivery products.
    Ito S; Taylor M; Mori S; Thorne D; Nishino T; Breheny D; Gaça M; Yoshino K; Proctor C
    Toxicol Lett; 2019 Oct; 315():14-22. PubMed ID: 31400404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New ideas, old problems? Heated tobacco products - a systematic review.
    Jankowski M; Brożek GM; Lawson J; Skoczyński S; Majek P; Zejda JE
    Int J Occup Med Environ Health; 2019 Oct; 32(5):595-634. PubMed ID: 31584041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heated tobacco product use, its correlates, and reasons for use among Mexican smokers.
    Cruz-Jiménez L; Barrientos-Gutiérrez I; Zavala-Arciniega L; Arillo-Santillán E; Gallegos-Carrillo K; Rodríguez-Bolaños R; Gravely S; Thrasher JF
    Drug Alcohol Depend; 2022 Mar; 232():109283. PubMed ID: 35134734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exposure to aerosol extract from heated tobacco products causes a drastic decrease of glutathione and protein carbonylation in human lung epithelial cells.
    Nishimoto-Kusunose S; Sawa M; Inaba Y; Ushiyama A; Ishii K; Hattori K; Ogasawara Y
    Biochem Biophys Res Commun; 2022 Jan; 589():92-99. PubMed ID: 34896781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro toxicological evaluation of glo menthol and non-menthol heated tobacco products.
    Keyser BM; Leverette R; McRae R; Wertman J; Shutsky T; Jordan K; Szeliga K; Makena P
    Toxicology; 2024 May; 504():153801. PubMed ID: 38614204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interconversion of nicotine enantiomers during heating and implications for smoke from combustible cigarettes, heated tobacco products, and electronic cigarettes.
    Moldoveanu SC
    Chirality; 2022 Apr; 34(4):667-677. PubMed ID: 35088460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple endpoint in vitro toxicity assessment of a prototype heated tobacco product indicates substantially reduced effects compared to those of combustible cigarette.
    Chapman F; Sticken ET; Wieczorek R; Pour SJ; Dethloff O; Budde J; Rudd K; Mason E; Czekala L; Yu F; Simms L; Nahde T; O'Connell G; Stevenson M
    Toxicol In Vitro; 2023 Feb; 86():105510. PubMed ID: 36372310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of smoke and aerosol deliveries from combustible cigarettes, heated tobacco products and electronic nicotine delivery systems in the Vitrocell® Mammalian 6/48 exposure module.
    Keyser BM; Leverette R; Hollings M; Seymour A; Weidman RA; Bequette CJ; Jordan K
    Toxicol Rep; 2022; 9():1985-1992. PubMed ID: 36518380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.